European Conference on Interventional Oncology

April 28 - May 1 | Palma de Mallorca, ES

April 28 - May 1 | Palma de Mallorca, ES

April 28 - May 1 | Palma de Mallorca, ES

April 28 - May 1 | Palma de Mallorca, ES

April 28 - May 1 | Palma de Mallorca, ES


Dr. Ganesh Vigneswaran

Presenting author, “Safety and Efficacy of Chemosaturation with Percutaneous Hepatic Perfusion of Melphalan for metastatic uveal melanoma: An 8-year retrospective study of 250 interventions in 81 patients.”

Why did you choose ECIO to submit your scientific abstract?

Vigneswaran: My supervisor mentioned to me that ECIO would be a great platform to present our work on M-PHP, and he was right. ECIO was an excellent platform to introduce advancements in research on oncological interventional treatments on the European stage. In order to get the best out of a piece of scientific work, it is critical to present your work in the right place, at the right time and to the right people. ECIO fulfils all these parameters. I wanted to get specific feedback on our work on M-PHP, in order to ascertain the strengths and weaknesses and to help guide our future work.

Are there any special considerations to take into account when submitting a scientific abstract?

It is really important to be clear on how any scientific work would fit in with clinical practice and any improvement in patient care. Furthermore, focus on the task at hand – with an emphasis on how treatments fit in with current interventional and non-interventional oncological treatments. It is useful to analyse data in a way that can be directly compared to other treatment modalities e.g., survival analysis with Kaplan-Meier curves or progression-free survival.

How did you find the submission process?

The submission process was smooth and similar to other conferences organised by CIRSE. No problems here!

Do you have any tips for physicians considering submitting an abstract?

I would advocate submitting to ECIO for any oncology related interventional work. My tip would be to submit early preliminary work. Waiting to ‘finish’ your work before submitting a study is all well and good, but I think this is missing a real trick. Submitting preliminary work is useful for getting feedback early enough to allow you to refine your scientific method and improve overall quality, thereby raising your level for final publication.

Will you submit an abstract for ECIO 2023 as well?

Absolutely! If it is anything like ECIO 2022, there is a lot to gain by presenting on the European stage.